Growth of Airways and Lung Parenchyma in Normal Infants
Growth of Airways and Lung Parenchyma in Normal Infants
批准号:
7368051
负责人:
Robert S. Tepper
金额:
$40.16万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-03-01 至 2010-02-28
关键词:
AdultAgeAge-YearsAlveolarAlveolusAnimalsAreaArtsAutopsyBirthBorderline Personality DisorderBronchopulmonary DysplasiaCell ProliferationChildhoodChronicClinicalClinical TrialsComputer SimulationConflict (Psychology)Continuous Positive Airway PressureDataDelivery RoomsDevelopmentDiffuseDiffusionEarly treatmentEffectivenessEnrollmentEnvironmental air flowExcisionFerretsFunctional disorderGasesGrowthGrowth and Development functionHeterogeneityHumanImageInfantInstitutionInterventionKnowledgeLaboratoriesLifeLiving WillsLungLung diseasesMaintenanceMeasurementMeasuresMechanical ventilationMechanicsMethodologyMorphologic artifactsMotionNational Institute of Child Health and Human DevelopmentNeonatalNoble GasesNumbersOryctolagus cuniculusOutcomePatternPeripheralPhysiologicalPregnancyPremature BirthPremature InfantPropertyPulmonary Diffusing CapacityRangeResearchResearch PersonnelResolutionRespiratory distressRespiratory physiologyRoleStagingStructureStructure of parenchyma of lungSurfaceTechniquesTherapeuticThickTimeTissuesToddlerUncertaintyVital capacityWeekX-Ray Computed Tomographyage effectage groupairway obstructiondensitydesignexperienceimprovedin vivoinfancylung developmentlung injurylung volumepremature lungsprogramsprophylacticrapid growthrespiratorysizesurfactantthree dimensional structuretwo-dimensional
中文摘要
该提案将应用最先进的技术来评估肺的正常生长和发育
婴儿和幼儿的软组织,这是一个重要且难以评估的年龄组。了解肺
生命早期的生长对于设计治疗策略以促进肺发育的婴儿至关重要。
疾病我们还将评估与早产相关的慢性肺部后遗症,以及
比较两种不同的呼吸支持策略对肺结构和功能的影响,
早产儿我们的实验室开发了评估用力呼气动作的方法,
婴儿,我们已经采用了这种技术来测量婴儿的单次呼吸弥散能力,作为一种
用于气体交换的表面积的体内评估。此外,获得高分辨率CT的技术
在没有来自呼吸运动的伪影的情况下,
肺实质的定量测量!组织密度以及气道大小和壁厚。
肺内的通气不均匀性也将通过惰性气体的洗脱研究进行评估,
不同的扩散率。最后,我们将扩展我们的传导气道的计算模型,以包括
腺泡结构,这将有助于解释生理数据和机制,
早产儿肺功能障碍。
具体目标#1:确定实质组织与肺泡体积之间的关系,
肺的正常生长
我们假设,在生命的头两年,肺实质表面积和肺泡体积
随着体细胞的生长而增加;然而,表面积与体积的比率保持不变,而
肺内的通气变得更加均匀。
具体目标#2:确定早产的肺部后遗症并评估
肺部后遗症的早期治疗策略。
我们假设早产会阻碍肺实质的生长和发育,
矫正年龄为1岁时的气道。此外,启动持续气道正压通气(CPAP)和
极早产儿出生时的允许性呼吸策略将改善肺生长和肺功能
与早期表面活性剂和常规通气治疗相比。
英文摘要
This proposal will apply state-of-the-arttechniques to assess normal growth and development of the lung
parenchyma in infants and toddlers, an important and difficult age group to evaluate. Understanding lung
growth early in life is critical for designing therapeutic strategies to promote lung growth in infants with lung
disease. We will also evaluate the chronic pulmonary sequelae related to premature birth, as well as
compare the effects upon lung structure and function of two different strategies for ventilatory support of very
premature infants. Our laboratory developed the methodology to assess forced expiratory maneuvers in
infants, and we have adapted this technique to measure single-breath diffusing capacity in infants, as an in-
vivo assessment of surface area for gas exchange. In addition, a technique to obtain high resolution CT
images in infants at elevated lung volumes without artifactsfrom respiratory motion, we will obtain in-vivo
quantitative measurements of the lung parenchyma! tissue density, as well as airway size and wall thickness.
Ventilation inhomogeneity within the lung will also be assessed from washout studies of inert gases with
differing diffusivity. Lastly, we will extend our computational model of the conducting airways to include the
acinar structure, which will assist in interpreting the physiologic data and mechanisms contributing to
pulmonary dysfunction in infants born prematurely.
SPECIFIC AIM # 1: Determine the relationship between parenchymal tissue and alveolar volume with
normal lung growth early in life.
We hypothesize that during the first two years of life that parenchymal surface area and alveolar volume
increase with somatic growth; however, the ratio of surface area to volume remains constant, while
ventilation within the lung becomes more homogenous.
SPECIFIC AIM # 2: Determine the pulmonary sequelae of premature birth and assessthe effectivenessof
early treatment strategies upon the pulmonary sequelae.
We hypothesize that premature birth impedes growth and development of the lung parenchyma and the
airways at a corrected-age of 1-year. In addition, initiating continuous positive airway pressure (CPAP) and a
permissive ventilatory strategy in very premature infants at birth will improve lung growth and lung function
compared to treatment with early surfactant and conventional ventilation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung Growth in Infants and Toddlers Residing at High Altitude
-
批准号:7343128
-
项目类别:
-
资助金额:$3.19万
-
财政年份:2008
-
负责人:Robert S. Tepper
-
依托单位:
Lung Growth in Infants and Toddlers Residing at High Altitude
-
批准号:7744033
-
项目类别:
-
资助金额:$2.54万
-
财政年份:2008
-
负责人:Robert S. Tepper
-
依托单位:
Lung Growth in Infants and Toddlers Residing at High Altitude
-
批准号:7544967
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2008
-
负责人:Robert S. Tepper
-
依托单位:
Airway as Target Organ in Infants with Atopic Dermatitis
-
批准号:6951836
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2004
-
负责人:Robert S. Tepper
-
依托单位:
Airway as Target Organ in Infants with Atopic Dermatitis
-
批准号:7101917
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2004
-
负责人:Robert S. Tepper
-
依托单位:
Airway as Target Organ in Infants with Atopic Dermatitis
-
批准号:7440227
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2004
-
负责人:Robert S. Tepper
-
依托单位:
Airway as Target Organ in Infants with Atopic Dermatitis
-
批准号:7254066
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2004
-
负责人:Robert S. Tepper
-
依托单位:
Airway as Target Organ in Infants with Atopic Dermatitis
-
批准号:6831012
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2004
-
负责人:Robert S. Tepper
-
依托单位:
AIRWAY RESPONSE--MATURATION OF MECHANICAL DETERMINANTS
-
批准号:2486907
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1997
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:7218682
-
项目类别:
-
资助金额:$40.35万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
GROWTH OF AIRWAYS AND LUNG PARENCHYMA IN NORMAL INFANTS
-
批准号:2668736
-
项目类别:
-
资助金额:$41.0万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:7571634
-
项目类别:
-
资助金额:$44.83万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:7105140
-
项目类别:
-
资助金额:$41.34万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:6400692
-
项目类别:
-
资助金额:$35.67万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
GROWTH OF AIRWAYS AND LUNG PARENCHYMA IN NORMAL INFANTS
-
批准号:2378836
-
项目类别:
-
资助金额:$39.42万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
GROWTH OF AIRWAYS AND LUNG PARENCHYMA IN NORMAL INFANTS
-
批准号:2883261
-
项目类别:
-
资助金额:$42.64万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:6537168
-
项目类别:
-
资助金额:$35.73万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
GROWTH OF AIRWAYS AND LUNG PARENCHYMA IN NORMAL INFANTS
-
批准号:2232266
-
项目类别:
-
资助金额:$41.85万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:6603990
-
项目类别:
-
资助金额:$35.67万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
Growth of Airways and Lung Parenchyma in Normal Infants
-
批准号:6771154
-
项目类别:
-
资助金额:$35.61万
-
财政年份:1996
-
负责人:Robert S. Tepper
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: